TINY

ProShares Nanotechnology ETF

TechnologyPSEProShares ETF
$83.16
$-0.08 (-0.10%)
Delayed ≥20 min · Aug 13, 2026

Key Statistics

Net Assets (AUM)
$10.39M
Expense Ratio
See prospectus
Previous Close
$83.24
Day Range
- – -
52-Week Range
$43.05 – $97.12
Volume
2.48K
Avg Vol (50D)
-
Beta
1.58

Historical Performance

1M
-2.81%
3M
-1.54%
6M
+27.19%
YTD
+56.25%
1Y
+82.98%
3Y
+121.66%
5Y

Total return including reinvested distributions, from adjusted closing prices.

Price History

Price history is being compiled for this fund.

Top Holdings

INVESCO GOVT AND AGCY LEX 5.92%
Onto Innovation, Inc. 5.50%
Applied Materials, Inc. 5.50%
JGC Holdings Corp. 5.39%
SCREEN Holdings Co. Ltd. 5.34%
Lam Research Corp. 5.11%
Entegris, Inc. 4.98%
ASML Holding NV 4.74%
ACM Research, Inc. 4.62%
nLight, Inc. 4.34%
Ultra Clean Holdings, Inc. 4.26%
Taiwan Semiconductor Manufacturing Co. Ltd. 4.21%
Cabot Corp. 3.88%
Canon, Inc. 3.65%
LG Chem Ltd. 3.60%
Axcelis Technologies, Inc. 3.57%
Bruker Corp. 3.54%
Jeol Ltd. 3.54%
NVIDIA Corp. 3.01%
Broadcom, Inc. 2.98%
Veeco Instruments, Inc. 2.85%
Novavax, Inc. 2.55%
Nanobiotix SA 2.26%
SkyWater Technology, Inc. 2.20%
Park Systems Corp. 2.19%

Top 25 holdings as of Feb 28, 2026 · source: SEC N-PORT. Full holdings & prospectus →

About TINY

The Fund invests in financial instruments that ProShare Advisors believes, in combination, should track the performance of the Index.The Index is designed to measure the performance of companies that have business operations in the field of nanotechnology. The index provider uses a natural language processing algorithm to identify companies that fall into one or more of the following categories: (1) production of nanotechnology, which can be defined as the use of matter on an atomic and molecular level; (2) active in the fields of nanomedicine, nanomaterials, nanoelectronics, nanometrology or molecular nanotechnology; and (3) development of technologies that promote advances in or research related to nanotechnologies.The index provider determines whether a company falls intothose categories by using an automated scan of company filings and other public information to search for terms and phrases which identify companies that have or are expected to have significant exposure to nanotechnology. The index provider reviews each company and excludes any company that does not have relevant business exposure. The identified companies are then ranked based on the level of exposure to nanotechnology, as determined by the automated scan. The top 30 companies are selected into the Index. Selected companies are weighted based on market capitalization, subject to a 4.5% limit for any single company. The Index’s composition and the assigned weights are reevaluated every May and November. The Index is constructed and maintained by Solactive AG. More information about the Index can be found using the Bloomberg ticker symbol “SOLNANON.”Under normal circumstances, the Fund will invest at least 80% of its total assets in components of the Index or in instruments with similar economic characteristics.The Fund will invest principally in the financial instruments listed below.●Equity Securities — Common stock issued by public companies.●Depositary Receipts — The Fund may invest in depositary receipts, which principally include:○American Depositary Receipts (ADRs), which represent the right to receive securities of foreign issuers deposited in a bank or trust company and are an alternative to purchasing the underlying securities in their national markets and currencies.○Global Depositary Receipts (GDRs), which are receipts for shares in a foreign-based corporation traded in capital markets around the world.ProShare Advisors uses a mathematical approach to investing in which it determines the type, quantity and mix of investment positions that it believes, in combination, the Fund should hold to produce returns consistent with its investment objective. The Fund seeks to remain fully invested at all times in financial instruments that, in combination, provide exposure consistent with the investment objective, without regard to market conditions, trends or direction. The Fund will generally use a “replication strategy” to achieve its investment objective, meaning that it will invest in all of the component securities of the Index in approximately the same proportion as the Index. However, the Fund may also use a “representative sampling” strategy to invest in or gain exposure to only a representative sample of the securities in the Index or to securities not contained in the Index or in financial instruments, with the intent of obtaining exposure with aggregate characteristics similar to those of the Index. For example, the Fund may utilize a representative sampling strategy when the Advisor believes a replication strategy might be detrimental or disadvantageous to shareholders, such as when buying each security in an Index is impracticable or inefficient, or when there are practical difficulties or additional costs involved in replicating an Index. The Fund also may use representative sampling if the Advisor believes one or more securities in the Index becomes illiquid, unavailable or less liquid, or as a result of legal restrictions or limitations (such as tax diversification requirements) that apply to the Fund.Please see “Investment Objectives, Principal Investment Strategies and Related Risks” in the Fund’s Prospectus for additional details.

Data for TINY is aggregated from third-party providers (Tiingo, Nasdaq, Finnhub) and SEC filings, may be delayed at least 20 minutes, and may be incomplete or contain errors. Nothing here is investment advice. Verify with the official prospectus before investing.